Epidermal growth factor receptor and variant III targeted immunotherapy

Immunotherapeutic approaches to cancer have shown remarkable promise. A critical barrier to successfully executing such immune-mediated interventions is the selection of safe yet immunogenic targets. As patient deaths have occurred when tumor-associated antigens shared by normal tissue have been tar...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Congdon, Kendra L., Gedeon, Patrick C., Suryadevara, Carter M., Caruso, Hillary G., Cooper, Laurence J.N., Heimberger, Amy B., Sampson, John H.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2014
Materias:
Invited Reviews
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4207138/
https://ncbi.nlm.nih.gov/pubmed/25342601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou236
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares